Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of atomoxetine on fidelity of neural representations in healthy adults
NL-OMON38650Active, not recruiting
- Sponsor
- Leiden University
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of atomoxetine (2 arms), sponsored by Leiden University. Primary endpoints: fMRI-based fidelity of cortical representation, Pupil diameter and 3 more. Started May 2013; status: active, not recruiting.
02
Drugs
atomoxetine
Beyond the preview
Go deeper on NL-OMON38650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38650.